Standard Conventional Radiotherapy
Radiation20Gy in 5 fractions
NCT Number: NCT06391242
This study is being done to answer the following question: Is Stereotactic Body Radiation Therapy or SBRT (a form of radiation therapy which can deliver high doses of radiation to the specific painful area of the body most affected by cancer, while keeping the radiation beams away from the healthy parts of the body that surround the cancer) better for pain relief than the standard treatment of conventional radiation therapy or CRT (a form of radiation therapy which delivers radiation to the painful area but can also negatively affect other parts of the body in the same area)
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 3
BCCA - Vancouver, Vancouver, British Columbia, Canada
This is a multi-centre, phase III randomized controlled trial comparing SBRT to conventional palliative EBRT in patients with solid tumours and a dominant painful non-spine bone metastasis as defined by a worst pain score of 2 or greater. 230 participants will be enrolled to the study. Participants will have radiation for 5 treatments (conventional palliative EBRT 20Gy/5; SBRT 30Gy/5 or 35Gy/5) and then will be followed for pain response and radiological progression at 3 and 6 months post treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
20Gy in 5 fractions
30 or 35Gy in 5 fractions
Time frame: 27 months
Time frame: 27 months
Time frame: 27 months
Time frame: 27 months
Time frame: 27 months
Time frame: 27 months
Time frame: 27 months
Time frame: 27 months
Time frame: 27 months
Contact information is provided by the study sponsor or research team.
Canadian Cancer Trials Group
Network
A Randomized Phase III Trial Comparing Stereotactic Body Radiotherapy to Conventional Palliative Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Participants With Painful Non-Spine Bone Metastases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07415564
Cancer Metastatic, Neoplasm Metastasis
Tucson, Arizona, United States
View Trial DetailsNCT07583654
Cancer Metastatic, Neoplasm Metastasis
Chengdu, Sichuan, China
View Trial DetailsNCT05232409
Cancer Metastatic, Metastatic Solid Tumor
Paramus, New Jersey, United States
View Trial DetailsNCT05096923
Cancer, Cancer Metastatic
Chapel Hill, North Carolina, United States
View Trial Details